JFL Life Sciences (NSE:JFLLIFE) Stock Based Compensation: ₹0.0 Mil (TTM As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JFLLIFE JFL Life Sciences Ltd NSE:JFLLIFE
67 GF Score
Price ₹11.25
GF Value ₹36.15
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is JFL Life Sciences Stock Based Compensation?

JFL Life Sciences NSE:JFLLIFE -0.88% 67 Stock Based Compensation is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:JFLLIFE with a GF Score™ of 67/100 and a GF Value™ of ₹36.15 (Significantly Undervalued). The stock has 3 warning signs investors should review.

JFL Life Sciences's Stock Based Compensation for the six months ended in Mar. 2025 was ₹0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

JFL Life Sciences Stock Based Compensation Related Terms

JFL Life Sciences Stock Based Compensation Historical Data

* Premium members only.

The historical data trend for JFL Life Sciences's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JFL Life Sciences Stock Based Compensation Chart

JFL Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Stock Based Compensation
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

JFL Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Stock Based Compensation Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:JFLLIFE
67GF Score
JFL Life Sciences Ltd NSE:JFLLIFE
Stock Based Compensation is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JFL Life Sciences Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

What does a Stock Based Compensation of ₹0.0 Mil mean?
JFL Life Sciences (NSE:JFLLIFE) has a Stock Based Compensation of ₹0.0 Mil as of Mar. 2025. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for JFL Life Sciences and its competitors.
Is JFL Life Sciences' Stock Based Compensation too high?
JFL Life Sciences' current Stock Based Compensation is ₹0.0 Mil. Overall, JFL Life Sciences has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JFL Life Sciences' Stock Based Compensation compare to ZTS?
JFL Life Sciences' Stock Based Compensation of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Stock Based Compensation for a Drug Manufacturers company?
A good Stock Based Compensation depends on the Drug Manufacturers industry context. However, Stock Based Compensation should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Stock Based Compensation mean?
A high Stock Based Compensation can signal that a stock is expensive relative to its fundamentals. Stock based compensation is the amount of company stock issued as employee benefits. View historical data for JFL Life Sciences and its competitors. JFL Life Sciences's current Stock Based Compensation is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JFL Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, JFL Life Sciences (NSE:JFLLIFE) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹36.15, compared to a current price of ₹11.25 — trading 68.9% below its estimated fair value. The current Stock Based Compensation is ₹0.0 Mil. JFL Life Sciences' overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Stock Based Compensation calculated?
Stock Based Compensation is calculated from a company's financial statements. For JFL Life Sciences (NSE:JFLLIFE), the current Stock Based Compensation is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JFL Life Sciences (NSE:JFLLIFE) Overvalued in 2026?

Based on GuruFocus' analysis, JFL Life Sciences stock appears to be undervalued. The current stock price of ₹11.25 is trading 68.9% below its estimated GF Value™ of ₹36.15. GuruFocus considers JFL Life Sciences to be Significantly Undervalued.

Key valuation signals for NSE:JFLLIFE:

  • Stock Based Compensation: ₹0.0 Mil
  • GF Value™: ₹36.15 vs. price of ₹11.25 (68.9% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the NSE:JFLLIFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

JFL Life Sciences Business Description

Address Jodhpur Cross Road, 309, Satyam Mall, Opposite Saman Complex, Near Vishweshwar Mahadev Mandir, Settelite, Ahmedabad, GJ, IND, 380015
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
67GF Score

Get the complete analysis for NSE:JFLLIFE

Stock Based Compensation is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹11.25
Price
₹36.15
GF Value